YM268/NN
increases/VBZ
the/DT
glucose/NN
uptake/NN
,/,
cell/NN
differentiation/NN
,/,
and/CC
mRNA/NN
expression/NN
of/IN
glucose/NN
transporter/NN
in/IN
3T3-L1/NN
adipocytes/NNS
./.

The/DT
purpose/NN
of/IN
this/DT
study/NN
was/VBD
to/TO
examine/VB
the/DT
effects/NNS
of/IN
bis[4-[2,4-dioxo-5-thiazolidinyl)methyl]phenyl]/NN
methane/NN
(/(
YM-268/NN
)/)
,/,
a/DT
thiazolidinedione/JJ
derivative/NN
,/,
on/IN
glucose/NN
uptake/NN
,/,
adipocyte/NN
differentiation/NN
through/IN
peroxisome/NN
proliferator-activated/JJ
receptor/NN
gamma/NN
(/(
PPARgamma/NN
)/)
,/,
and/CC
phosphatidylinositol/NN
3-kinase/NN
(/(
PI/NN
3-kinase/NN
)/)
activity/NN
in/IN
cultured/VBN
cells/NNS
./.
=====
YM268/NN
and/CC
pioglitazone/NN
dose-dependently/RB
increased/VBD
the/DT
2-deoxyglucose/NN
uptake/NN
in/IN
3T3-L1/NN
cells/NNS
./.
=====
YM268/NN
facilitated/VBD
the/DT
insulin-stimulated/JJ
triglyceride/NN
accumulation/NN
in/IN
3T3-L1/NN
adipocytes/NNS
and/CC
increased/VBD
the/DT
mRNA/NN
expression/NN
of/IN
fatty/JJ
acid-binding/JJ
protein/NN
./.
=====
YM268/NN
,/,
with/IN
and/CC
without/IN
insulin/NN
,/,
increased/VBD
the/DT
mRNA/NN
expression/NN
of/IN
glucose/NN
transporter/NN
isoforms/NNS
such/JJ
as/IN
GLUT1/NN
and/CC
GLUT4/NN
,/,
indicating/VBG
enhancement/NN
of/IN
adipocyte/NN
differentiation/NN
./.
=====
Additionally/RB
,/,
YM268/NN
and/CC
pioglitazone/NN
showed/VBD
activity/NN
of/IN
the/DT
PPARgamma/NN
ligand/NN
,/,
a/DT
member/NN
of/IN
the/DT
nuclear/JJ
receptor/NN
superfamily/NN
responsible/JJ
for/IN
adipogenesis/NN
./.
=====
To/TO
examine/VB
the/DT
possible/JJ
involvement/NN
of/IN
the/DT
increased/VBN
activity/NN
of/IN
PI/NN
3-kinase/NN
in/IN
YM268-stimulated/JJ
glucose/NN
uptake/NN
,/,
the/DT
enzyme/NN
activity/NN
was/VBD
estimated/VBN
by/IN
measuring/VBG
the/DT
phosphatidylinositol-3,4,5-trisphosphate/NN
(/(
PI-3,4,5-P3/NN
)/)
concentration/NN
in/IN
human/JJ
monocytic/JJ
cells/NNS
./.
=====
Insulin/NN
dose-dependently/RB
increased/VBD
the/DT
PI-3,4,5-P3/NN
production/NN
but/CC
YM268/NN
had/VBD
no/DT
significant/JJ
effect/NN
on/IN
the/DT
insulin-dependent/JJ
and/CC
-independent/JJ
PI/NN
3-kinase/NN
activation/NN
./.
=====
These/DT
results/NNS
indicate/VBP
that/IN
the/DT
mechanism/NN
by/IN
which/WDT
YM268/NN
increased/VBD
glucose/NN
uptake/NN
,/,
may/MD
be/VB
accounted/VBN
for/IN
in/IN
part/NN
by/IN
the/DT
enhancement/NN
of/IN
GLUT1/NN
and/CC
GLUT4/NN
expression/NN
through/IN
PPARgamma/NN
activation/NN
./.